Russia’s success in the future depends largely on the dynamics of human capital. Health and education are two main human capital issues. Leadership in the global economy will increasingly be determined by the country’s competitiveness in the global markets of educational and medical technologies and services. In this connection, in the industry whose orientation is limited primarily to the detection and treatment of diseases, healthcare should become an integrated interdisciplinary system that can not only more effectively solve medical and social problems, but also be one of the main drivers of the growth of the Russian economy.

This report by Bain & Company, an international consulting firm, studies the rising dissatisfaction of European physicians with healthcare systems in their countries and suggests possible ways to improve the situation.

In the run-up to SPIEF, Tatsuo Yasunaga, President and CEO of Mitsui & Co, one of the largest investment companies in Japan and the oldest in the Russian market, tells about the terms of business development between the countries.

Deloitte CIS Research Centre has produced an analytical report about the situation on the Russian pharmaceutical market in 2017 and its prospects for growth in 2018.